174 related articles for article (PubMed ID: 10835502)
21. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
[TBL] [Abstract][Full Text] [Related]
22. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
24. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
[TBL] [Abstract][Full Text] [Related]
25. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis.
Usuda J; Okunaka T; Furukawa K; Tsuchida T; Kuroiwa Y; Ohe Y; Saijo N; Nishio K; Konaka C; Kato H
Int J Cancer; 2001 Aug; 93(4):475-80. PubMed ID: 11477550
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy with talaporfin sodium induces dose- and time-dependent apoptotic cell death in malignant meningioma HKBMM cells.
Ichikawa M; Akimoto J; Miki Y; Maeda J; Takahashi T; Fujiwara Y; Kohno M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():29-34. PubMed ID: 30389626
[TBL] [Abstract][Full Text] [Related]
27. Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.
Kasuya K; Shimazu M; Suzuki M; Kuroiwa Y; Usuda J; Itoi T; Tsuchida A; Aoki T
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):313-21. PubMed ID: 20464561
[TBL] [Abstract][Full Text] [Related]
28. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
[TBL] [Abstract][Full Text] [Related]
29. Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation.
Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K
Lasers Surg Med; 2000; 26(1):83-9. PubMed ID: 10637007
[TBL] [Abstract][Full Text] [Related]
30. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
Tsai SR; Yin R; Huang YY; Sheu BC; Lee SC; Hamblin MR
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):123-30. PubMed ID: 25462575
[TBL] [Abstract][Full Text] [Related]
31. Preclinical in vivo evaluation of NPe6-mediated photodynamic therapy on normal vasculature.
Moy WJ; Patel SJ; Lertsakdadet BS; Arora RP; Nielsen KM; Kelly KM; Choi B
Lasers Surg Med; 2012 Feb; 44(2):158-62. PubMed ID: 22334298
[TBL] [Abstract][Full Text] [Related]
32. Excellent antitumor effects for gastrointestinal cancers using photodynamic therapy with a novel glucose conjugated chlorin e6.
Nishie H; Kataoka H; Yano S; Yamaguchi H; Nomoto A; Tanaka M; Kato A; Shimura T; Mizoshita T; Kubota E; Tanida S; Joh T
Biochem Biophys Res Commun; 2018 Feb; 496(4):1204-1209. PubMed ID: 29408755
[TBL] [Abstract][Full Text] [Related]
33. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
Yan YJ; Zheng MZ; Chen ZL; Yu XH; Yang XX; Ding ZL; Xu L
Bioorg Med Chem; 2010 Sep; 18(17):6282-91. PubMed ID: 20691601
[TBL] [Abstract][Full Text] [Related]
34. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
Kato H; Furukawa K; Sato M; Okunaka T; Kusunoki Y; Kawahara M; Fukuoka M; Miyazawa T; Yana T; Matsui K; Shiraishi T; Horinouchi H
Lung Cancer; 2003 Oct; 42(1):103-11. PubMed ID: 14512194
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells.
Miki Y; Akimoto J; Moritake K; Hironaka C; Fujiwara Y
Lasers Med Sci; 2015 Aug; 30(6):1739-45. PubMed ID: 26109138
[TBL] [Abstract][Full Text] [Related]
36. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
Webber J; Leeson B; Fromm D; Kessel D
J Photochem Photobiol B; 2005 Feb; 78(2):135-40. PubMed ID: 15664500
[TBL] [Abstract][Full Text] [Related]
37. Photobleaching of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
Spikes JD; Bommer JC
Photochem Photobiol; 1993 Sep; 58(3):346-50. PubMed ID: 8234467
[TBL] [Abstract][Full Text] [Related]
38. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
39. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I
Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.
Gomer CJ; Ryter SW; Ferrario A; Rucker N; Wong S; Fisher AM
Cancer Res; 1996 May; 56(10):2355-60. PubMed ID: 8625311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
